Integrating Iron Overload Diagnosis with Electrocardiographic Abnormalities: Bridging Laboratory Findings to Primary Care Practice

  • Xinqi Liu Family Medicine Department, Beijing United Family Hospital, Beijing 100015, China
  • Xinhan Liu Pediatric Cardiac Center, Capital Medical University Affiliated Beijing Anzhen Hospital, Beijing 100029, China
  • Roohollah Changizi Family Medicine Department, Beijing United Family Hospital, Beijing 100015, China
  • Fei Sun Family Medicine Department, Beijing United Family Hospital, Beijing 100015, China
  • Xinlian Jin Family Medicine Department, Beijing United Family Hospital, Beijing 100015, China
Keywords: Ferritin, Electrocardiogram, ECG

Abstract

Objective: To investigate the diagnostic status and electrocardiographic correlates in patients with biochemical evidence of iron overload. Methods: We conducted a retrospective cohort study of patients in our hospital with ferritin levels exceeding 500 ng/mL between January 1, 2011, and October 24, 2022 (corresponding to the pre-COVID-19 pandemic period in Beijing). Using ICD-10-CM coded medical records, we assessed the following: definitive diagnostic characterization (genetic or acquired), electrocardiographic (ECG) completion rates, and the prevalence of ECG abnormalities. Statistical analyses, encompassing chi-square tests and correlation studies, were performed using SPSS Statistics software (version 27.0). Results: Except for cases of malignancy, infectious diseases, hematological diseases, chronic diseases, for the unexplained diagnosis group found elevated ferritin during annual health checkup, there were 17 cases in the group with ferritin above 1,000 ng/ml and 36 cases in the group with ferritin ranging from 500 to 1,000 ng/ml, accounting for 23.2% and 25.8% of the entire ferritin analysis respectively, and the total proportion in the entire analysis was 24.0%. Among the cases indicating ferritin higher than 500ng/ml, 24.0% of the cases were of unknown diagnosis. ECG acquisition rate for was 55.7%, with 24% demonstrating abnormalities, including atrial fibrillation, sinus tachycardia arrhythmia, atrioventricular block, prolonged QT interval, T-wave inversion, and ST-segment depression. Conclusion: The study revealed that the proportion of unexplained diagnoses of ferritin overload remains relatively high, and the analysis of the ECG is also insufficient. There is a need to enhance clinicians’ awareness and attention to iron overload in both diagnosis and ECG analysis.

References

Eid R, Arab N, Greenwood M, 2017, Iron Mediated Toxicity and Programmed Cell Death: A Review and a Re-Examination of Existing Paradigms. Biochimica et Biophysica Acta, 1864(2): 399–430.

Zhao X, He Z, Liu L, et al., 2019, Comparative Study of Pathological Characteristics of 45 Patients With Primary and Secondary Hemochromatosis. Infect Dis Info, 32: 127–131.

Pinyopornpanish K, Tantiworawit A, Leerapun A, et al., 2023, Secondary Iron Overload and the Liver: A Comprehensive Review. Journal of Clinical and Translational Hepatology, 11(4): 932–941.

Schwartz K, Li Z, Schwartz D, et al., 2002, Earliest Cardiac Toxicity Induced by Iron Overload Selectively Inhibits Electrical Conduction. J Appl Physiol, 93(2): 746–751.

Feng Y, Cheng S, Luo Z, 2014, The Progress of Hereditary Hemochromatosis in China. Medical Recapitulate, 20: 1190–1193.

Ong S, Nicoll A, Delatycki M, 2016, How Should Hyperferritin Anemia Be Investigated and Managed? Eur J Intern Med, 33: 21–27.

Plays M, Muller S, Rodriguez R, 2021, Chemistry and Biology of Ferritin. Metallomics, 13(5): mfab021.

Hsu C, Senussi N, Fertrin K, et al., 2022, Iron Overload Disorders. Hepatology Communications, 6(8): 1842–1854.

Kawabata H, 2018, The Mechanisms of Systemic Iron Homeostasis and Etiology, Diagnosis, and Treatment of Hereditary Hemochromatosis. Int J Hematol, 107: 31–43.

Laudanski K, Ali H, Himmel A, e al, 2009, The Relationship Between Serum Ferritin Levels and Electrocardiogram Characteristics in Acutely Ill Patients. Experimental and Clinical Cardiology, 14(3): 38–41.

Mikkelsen L, Nordestgaard B, Schnohr P, et al., 2019, Increased Ferritin Concentration and Risk of Atrial Fibrillation and Heart Failure in Men and Women: Three Studies of the Danish General Population Including 35799 Individuals. Clinical Chemistry, 65(1): 180–188.

McKinnon E, Rossi E, Beilby J, et al., 2014, Factors That Affect Serum Levels of Ferritin in Australian Adults and Implications for Follow-Up. Clin Gastroenterol Hepatol, 12: 101–108.e4.

Kremastinos D, Farmakis D, 2011, Iron Overload Cardiomyopathy in Clinical Practice. Circulation, 124: 2253–2263.

Wang W, Wu T, Wang Y, et al., 2021, Involvement of Cardiac Structure and Function Between Primary and Secondary Hemochromatosis: A Comparative Study. Chinese Hepatology, 26(5): 542–546.

Adams P, 2015, Epidemiology and Diagnostic Testing for Hemochromatosis and Iron Overload. Int J Hematol, 37: 25–30.

Lv T, Zhang W, Xu A, et al., 2018, Non-HFE Mutations in Haemochromatosis in China: Combination of Heterozygous Mutations Involving HJV Signal Peptide Variants. Journal of Medical Genetics, 55(10): 650–660.

Yin X, Zhang Y, Gao H, et al., 2019, A Case Report of Hereditary Hemochromatosis Caused by Mutation of SLC40A1 Gene. Medicine, 98(44): e17526.

Carpenter J, Grasso A, Porter J, et al., 2013, On Myocardial Siderosis and Left Ventricular Dysfunction in Hemochromatosis. Journal of Cardiovascular Magnetic Resonance, 15(1): 24.

Published
2025-10-15